AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...
A clinical trial has found an injectable HIV treatment could be an effective prevention for the infection, NPR reported July 3. A clinical trial by drugmaker Gilead conducted a randomized study on ...
The Star Worldwide (English) on MSN
Kenya to begin once-in-six-months HIV prevention injection
Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Only two people taking twice-yearly lenacapavir in a ...
The New Times on MSN
Six-month HIV prevention injection set for rollout by year-end
The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the ...
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback